Upgrade

Sana Biotechnology, Inc.

SANA

Last
$2.79
Day
+0.0%
1y
-37.3%
5y
-86.1%
52w
-57.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0525d
EMA 21
3.01
EMA 50
3.22
EMA 200
3.46
20d high
-17.0%
5y high
-88.1%
5y range
7th
Website · 142 employees · United States

Positions held

Your positions

SANA isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-24
Hold
avoid
Signal
Strong Sell
Target
$3.11
Stop
$2.52
Stop distance
9.7%
Target vs last
+11.5%

Fundamentals

Market cap$835.22MEnterprise value$755.67MTrailing P/E—Forward P/E-5.03
PEG—Price / book5.41Beta2.19Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE-1.5%ROA-29.2%Debt / equity0.52
Current ratio1.38Free cash flow$4.13MAnalyst recommendationnoneMean target$8.43
52w high$6.5552w low$2.61

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q2
Revenue$0.0M$0.0M$0.0M$0.0M$0.0M
Op margin—————
Net income-$63.6M-$47.2M-$58.8M-$42.2M-$93.8M
Gross margin—————
Gross profit—————
Operating income-$65.4M-$48.6M-$61.2M-$43.5M-$50.4M

Yearly (6y)

20252024202320222021
Revenue$0.0M$0.0M$0.0M$0.0M—
Op margin—————
Net income-$244M-$267M-$283M-$269M—
Gross margin—————
Gross profit—————
Operating income-$206M-$271M-$286M-$273M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

SANA · daily-16.2% over 13 sessions
Close EMA21 EMA50 EMA200
2.632.823.013.203.392026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$94M-$70M-$47M-$23M$0M0%5%10%2025-Q22025-Q32025-Q42026-Q12026-Q2